Literature DB >> 16819435

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript.

K Halaburda, W Prejzner, D Szatkowski, J Limon, A Hellmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819435     DOI: 10.1038/sj.bmt.1705437

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic approaches to patients with hypereosinophilic syndromes.

Authors:  Hans-Uwe Simon; Amy Klion
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

2.  Response to imatinib mesylate in patients with hypereosinophilic syndrome.

Authors:  Maryam Arefi; Juan L García; M Montserrat Briz; Felipe de Arriba; Juan N Rodríguez; Guillermo Martín-Núñez; Joaquín Martínez; Javier López; Julio G Suárez; M José Moreno; M Angeles Merino; Norma C Gutiérrez; Jesús Marίa Hernández-Rivas
Journal:  Int J Hematol       Date:  2012-07-18       Impact factor: 2.490

Review 3.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

Review 4.  Eosinophilia in Hematologic Disorders.

Authors:  Lorenzo Falchi; Srdan Verstovsek
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 5.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

Review 6.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

7.  Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.

Authors:  Violaine Havelange; Jean-Baptiste Demoulin
Journal:  J Blood Med       Date:  2013-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.